克罗西作为神经保护剂:通过抗氧化,抗炎和肠脑轴调节向西方饮食诱导的认知功能障碍
Suresh Babu Kondaveeti1, Vrinda Gupta2, Aaqib Ahmad Dar2
1Symbiosis Medical college for Women, Symbiosis International (Deemed University), Pune, India.
ASN neuro
|December 19, 2025
概括
克罗西通过改善肠-大脑轴功能和大脑健康,显示出对西方饮食诱导的认知衰退的神经保护潜力. 为了临床应用,需要进一步的研究和先进的配方.
科学领域:
- 神经科学是一个神经科学.
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 西方饮食中含有大量脂肪,糖和加工食品,通过神经炎症,氧化应激和肠道失调引起认知功能障碍.
- 血脑屏障 (BBB) 的破坏和突触功能障碍是这些饮食模式的关键后果.
- 克罗西是一种天然的阿波卡罗类,显示出潜在的神经保护性质.
研究的目的:
- 批判性地评估克罗塞丁与改善西方饮食引起的认知衰退之间的机制联系.
- 在临床前和人类证据中区分支持良好的发现与投机的关联.
- 讨论克罗西的治疗前景,考虑到其局限性和潜在的先进配方.
主要方法:
- 对克罗西对神经炎症,氧化应激和肠道微生物群的影响进行临床前研究的综述.
- 对早期临床证据的分析,这些证据涉及克罗西对认知功能和大脑血流的影响.
- 评估克罗西的药理动力学特性,生物可用性挑战,以及潜在的先进的输送系统.
主要成果:
- 临床前数据强烈支持crocetin在减轻西方饮食引起的神经退行症的有效性.
- 早期的人类试验表明,使用crocetin可以改善记忆力,执行功能和大脑血流.
- 克罗西表现出神经保护机制,包括抗氧化活性,抗炎作用,增强线粒体功能和肠道微生物群调节.
结论:
- 克罗西显示出作为神经保护剂的显著潜力,可以预防西方饮食引起的认知衰退.
- 生物可用性和新陈代谢的限制需要开发用于临床转化的先进配方.
- 未来的研究应该专注于大规模试验和药理动力学优化,以确定克罗西的临床可行性.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
512
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
459
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
459
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K


